Stock Market News

Chimerix stock rises on FDA priority review for dordaviprone

Feb 18, 2025 - 15:00
 0
Chimerix stock rises on FDA priority review for dordaviprone
Read More

Tags:

Previous Article

Market Cap Game Show: An Un-Carrier, an Un-Company & an Un-Tripled Stock

Next Article

ConAgra Brands lowers 2025 sales and profit guidance, stock drops

Related Posts

Jfrog earnings beat by $0.05, revenue topped estimates

Feb 13, 2025  0

HSBC books 6.6% rise in annual profit; beats estimates

HSBC books 6.6% rise in annual profit; beats estimates

Feb 19, 2025  0

Sika posts strong growth in sales, profit, and cash flow

Sika posts strong growth in sales, profit, and cash flow

Feb 21, 2025  0